The Flyers method - mucking and grinding and fighting for gains

Like Dave Schultz and Bobby Clarke of the Philadelphia Flyers sometimes you just need to dump the puck in and then work hard, work hard to make something happen.

I dumped in today and sold some shares of good companies with good balance sheets that had 18-20 % gains , (GRMN) Garmin and (ADM) ArcherDanielsMidland. Sometimes, just like in hockey , you need to take shorter shifts, to get all four lines on the ice and keep everyone fresh. It just seemed like both issues were fully valued here.

I picked up some value stocks to plug in with defensive positions. I am not as bullish here as most of the soothsayers. I do not see a fast recovery at all. (BMY )Bristol Myers Squibb has a 6.2 % dividend yield, so you get paid to wait for a stock gain. They are also in a product partnership with Gilead Sciences , (GILD).

Foster Wheeler AG, (FWLT), a play on rebuilding infrastructure in heavy construction and engineeering. Both stocks are value plays that are lower beta volitility than Garmin and ADM. We'll see if we can get a quick goal here if the puck bounces right! These activities are in an IRA retirement account, so are a little bit more conservative picks.

Thanks,

freewilly

Summer Time - some pharma stocks to look at with a 2 year time horizon

Dendreon Corp., (Symbol DNDN), located in Seattle, Washington, trading around $24.50 is up today in a summer doldrums market. One analyst has moved the target price to $36.00 and on CNBC they off-handedly threw out a $49 target handle projected on the stock. Story here is a big cancer breakthrough in prostate cancer treatment.

Another stock to keep an eye on as we go into the next flu season is Gilead Sciences Inc., (Symbol GILD). Sometimes after a big flu threat year like with the swine flu the following year is even worse. This Forest City, Ca. company is very well positioned for medical solutions in this area. The stock trades at $45.36 today. (7/6) Last quarter earnings were growing at 24 % plus.

Either of these stocks could also be targets for buyout from the "bigger fish" in the pharma area. As always buy in with smaller positions and average in with your purchases.

Happy hunting, P.S. disclaimers. I have 37 years of personal trading experience, (and I have had many bumps and bruises along the way), but no degrees in finance or Series 7 licencing. These are just observations based on my experience.

Thanks,

Freewilly